Principal Financial Group Inc. Sells 60,807 Shares of Sotera Health (NASDAQ:SHC)

Principal Financial Group Inc. trimmed its stake in Sotera Health (NASDAQ:SHC) by 14.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 354,025 shares of the company’s stock after selling 60,807 shares during the period. Principal Financial Group Inc. owned 0.12% of Sotera Health worth $5,912,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of SHC. Retirement Systems of Alabama grew its holdings in shares of Sotera Health by 20.8% during the third quarter. Retirement Systems of Alabama now owns 185,779 shares of the company’s stock valued at $3,103,000 after buying an additional 32,051 shares during the last quarter. Sanctuary Advisors LLC increased its position in shares of Sotera Health by 154.4% during the 3rd quarter. Sanctuary Advisors LLC now owns 29,088 shares of the company’s stock valued at $486,000 after purchasing an additional 17,652 shares during the last quarter. Neo Ivy Capital Management bought a new position in Sotera Health in the third quarter worth approximately $720,000. Geode Capital Management LLC raised its holdings in Sotera Health by 19.4% in the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after purchasing an additional 447,186 shares during the period. Finally, Barclays PLC lifted its position in shares of Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock valued at $7,909,000 after buying an additional 298,085 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Trading Up 2.4 %

Shares of SHC opened at $13.68 on Thursday. The stock has a market cap of $3.87 billion, a PE ratio of 54.72 and a beta of 1.96. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The firm’s fifty day moving average is $14.05 and its two-hundred day moving average is $14.32.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. Sotera Health’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.18 EPS. Research analysts forecast that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on SHC shares. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Thursday, November 21st. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Finally, Citigroup boosted their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.